top of page

FREE SHIPPING ON ALL ORDERS OVER $300

  • SARMACEUTICALS S4 Andarine

SARMACEUTICALS S4 Andarine

C$90.00Price

Overview: S4, also known as Andarine or GTx-007, is a potent selective androgen receptor modulator (SARM) that selectively binds to androgen receptors in muscle and bone tissue. Its primary mechanism involves activating these receptors to promote anabolic effects while minimizing androgenic side effects in other tissues. Compared to other SARMs, S4 demonstrates a particularly high binding affinity and selectivity for androgen receptors, with an IC50 value of approximately 4 nM. This high selectivity contributes to its potent effects on muscle and bone tissue while potentially reducing unwanted androgenic effects.

 

Benefits:

  • Enhanced Muscle Growth: Promotes lean muscle mass development and strength gains.
  • Improved Body Composition: Facilitates fat loss while preserving muscle tissue.
  • Bone Density Support: May support bone health by enhancing bone mineral density.
  • Increased Vascularity: Contributes to improved muscle definition and vascularity.
  • Potential Therapeutic Applications: Demonstrates promise in treating muscle wasting conditions and osteoporosis.

 

Dosage and Usage: DOUBLE DOSED! 30mL bottle, 40mg/mL

Standard dosing for research purposes ranges from 25-50 mg per day. Administration is typically recommended in divided doses, 2-3 times daily due to its shorter half-life. Common research cycles last between 8-12 weeks.

 

Ingredients: S4 (Andarine) Solvents (DMSO, Propylene Glycol, Vegetable Glycerin) USP Grade

Additional Information: S4 is produced under stringent quality control standards, ensuring high purity and consistency. Each batch undergoes rigorous analytical testing to verify its composition and efficacy.

 

Disclaimer: This product is intended solely for laboratory research use only. Not for human consumption. Not for human or veterinary diagnostic or therapeutic use. Users should consult relevant literature and adhere to appropriate protocols. Not suitable for non-research use or by individuals under 18 years of age.

    bottom of page